scholarly article | Q13442814 |
P50 | author | Olivier Delattre | Q30119391 |
Brigitte Bressac-de Paillerets | Q43376253 | ||
P2093 | author name string | Jacques Grill | |
Pascale Varlet | |||
Stéphanie Puget | |||
Julien Masliah-Planchon | |||
Laurence Brugières | |||
Nicolas Sevenet | |||
Franck Bourdeaut | |||
Rachid Abbas | |||
Olivier Caron | |||
Sophie Huybrechts | |||
Dominique Valteau-Couanet | |||
Christelle Dufour | |||
Marine Guillaud-Bataille | |||
Léa Guerrini-Rousseau | |||
Fanny Fouyssac | |||
Anne-Isabelle Bertozzi | |||
Sophie Villebasse | |||
Marina Dimaria | |||
P2860 | cites work | Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome | Q24336457 |
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
Dissecting the genomic complexity underlying medulloblastoma | Q24621907 | ||
The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors | Q26764892 | ||
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition | Q27852966 | ||
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. | Q27853187 | ||
Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system | Q28270384 | ||
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group | Q28277811 | ||
Human homolog of patched, a candidate gene for the basal cell nevus syndrome | Q28281033 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome | Q28307305 | ||
Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy | Q30389898 | ||
Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature | Q30968980 | ||
Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature | Q31043687 | ||
Mutations in SUFU predispose to medulloblastoma | Q34133729 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
Basal cell carcinomas in gorlin syndrome: a review of 202 patients | Q34389057 | ||
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples | Q35837393 | ||
The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma | Q35993240 | ||
Novel mutations target distinct subgroups of medulloblastoma. | Q36143877 | ||
Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome | Q36406904 | ||
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus | Q36901551 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Family history of cancer among children with brain tumors: a critical review. | Q37050913 | ||
Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study | Q37375947 | ||
Targeted treatment for sonic hedgehog-dependent medulloblastoma. | Q38222028 | ||
Germline and somatic mutations in meningiomas. | Q38413198 | ||
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
Congenital anomalies and genetic syndromes in 173 cases of medulloblastoma | Q40919074 | ||
Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449 | Q42031842 | ||
Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations | Q42468615 | ||
Early diagnosis of nevoid basal cell carcinoma syndrome | Q42472273 | ||
Hedgehog Pathway Inhibition | Q42489608 | ||
High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. | Q42504937 | ||
Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation | Q42510080 | ||
Clinical and radiological features in young individuals with nevoid basal cell carcinoma syndrome | Q42511712 | ||
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone | Q46367739 | ||
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma | Q46959964 | ||
Identification of a SUFU germline mutation in a family with Gorlin syndrome. | Q51932422 | ||
Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). | Q53148301 | ||
Family cancer history and risk of brain tumors in children: results of the SEARCH international brain tumor study. | Q53220494 | ||
Loss of suppressor-of-fused function promotes tumorigenesis. | Q53334228 | ||
[Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant]. | Q55459584 | ||
Multiple skin hamartomata: a possible novel clinical presentation of SUFU neoplasia syndrome. | Q55460687 | ||
Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. | Q55471194 | ||
Retrospective family study of childhood medulloblastoma. | Q55471502 | ||
Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. | Q55476488 | ||
Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations | Q60035710 | ||
Vismodegib | Q84330539 | ||
P433 | issue | 8 | |
P921 | main subject | medulloblastoma | Q1333608 |
P304 | page(s) | 1122-1132 | |
P577 | publication date | 2017-11-24 | |
P1433 | published in | Neuro-Oncology | Q15724471 |
P1476 | title | Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis | |
P478 | volume | 20 |
Q92423194 | Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines |
Q91879154 | Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade |
Q88737429 | Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial |
Q91780113 | Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience |
Q89746478 | The pan-cancer landscape of prognostic germline variants in 10,582 patients |
Search more.